NVS · Novartis AG · Analyst Estimates
$160.50
+0.25 (+0.16%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$303.12B
Shares
1.89B
Volume · Nov 13
1.42M
Avg daily vol (3M)
2.11M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Analyst Estimates
Compare analyst forecasts for Novartis AG across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Pull consensus estimates through the analyst estimates API or MCP →Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-11-14 18:29 UTC · Publication dates shown per estimate · 8 metric / period groups
FY ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
8.67
|
9.07
|
9.38
|
8
|
9.13
|
8.83
|
8.85
|
8.82
|
0
|
0
|
— | — |
|
Revenue
USD
Publication date not stated |
56.47B
|
57.76B
|
58.86B
|
19
|
— | — | — | — | — | — | — | — |
FY ending 2027-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
9.30
|
9.93
|
10.49
|
9
|
9.94
|
9.80
|
9.84
|
9.87
|
0
|
1
|
5
|
5
|
|
Revenue
USD
Publication date not stated |
59.72B
|
61.71B
|
64.71B
|
20
|
— | — | — | — | — | — | — | — |
Q ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
2.19
|
2.23
|
2.31
|
3
|
2.22
|
2.10
|
2.10
|
2.10
|
— | — |
1
|
1
|
|
Revenue
USD
Publication date not stated |
14.45B
|
14.83B
|
15.24B
|
5
|
— | — | — | — | — | — | — | — |
Q ending 2027-03-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
2.21
|
2.27
|
2.33
|
2
|
2.27
|
2.33
|
2.33
|
2.33
|
0
|
0
|
— | — |
|
Revenue
USD
Publication date not stated |
14.05B
|
14.31B
|
14.57B
|
2
|
— | — | — | — | — | — | — | — |
Key facts
CIK
1114448
CUSIP
66987V109
13F (30d)
1276 filings
1161 filers
Visit website
Investor relations